Abstract
Anxiety disorders are common within primary care (PC) settings and are associated with patient functional impairment, distress, and high utilization of medical care services. Data from PC settings indicate that detection of anxiety disorders is low. Furthermore, adequate psychosocial and pharmacologic treatment of anxiety disorders in accordance with empirically validated guidelines remains low in PC. When patients do receive treatment or referrals from their PC providers, a bias exists for pharmacologic over psychological interventions despite theoretical strengths, empirical evidence, and long-term cost efficiency supporting the use of psychotherapeutic interventions such as cognitive-behavioral therapy (CBT). Objectives of this article include increasing awareness of the prevalence of anxiety disorders in PC, impairment associated with anxiety disorders, issues of detection of anxiety in PC, treatment model and components of CBT, and data supporting the application of CBT to PC to improve patient functioning.
Similar content being viewed by others
References and Recommended Reading
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), edn 4. Washington, DC: American Psychiatric Press; 1994.
Chavira DA, Stein MB, Bailey K, Stein MT: Child anxiety in primary care: prevalent but untreated. Depress Anxiety 2004, 20:155–164.
Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8–19.
Stein M, Sherbourne C, Craske M, et al.: Quality of care for primary care patients with anxiety disorders. Am J Psychiatry 2004, 161:2230–2237.
Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU: Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary care health care. Br J Psychiatry Suppl 1996, 30:38–43.
Weiller E, Bisserbe JC, Maier W, et al.: Prevalence and recognition of anxiety syndromes in five European primary care settings: a report from the WHO study on psychological problems in general health care. Br J Psychiatry 1998, 34:18–23.
Harman JS, Rollman BL, Hanusa BH, et al.: Physician office visits of adults for anxiety disorders in the United States, 1985–1998. J Gen Intern Med 2002, 17:165–172.
Young AS, Klap R, Sherbourne CD, Wells KB: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58:55–61.
Stein M: Attending to anxiety disorders in primary care. J Clin Psychiatry 2003, 64(Suppl 15):35–39.
Magee WJ, Eaton WW, Wittchen HU, et al.: Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996, 53:159–168.
Gross R, Olfson M, Gameroff MJ, et al.: Social anxiety disorder in primary care. Gen Hosp Psychiatry 2005, 27:161–168.
Leon AC, Portera L, Weissman MM: The social costs of anxiety disorders. Br J Psychiatry 1995, 27:19–22.
Ormel J, VonKorff M, Ustun TB, et al.: Common mental disorders and disability across cultures: results from the WHO Collaborative Study on psychological problems in general health care. JAMA 1994, 272:1741–1748.
Greenberg PE, Sisitsky R, Kessler RC, et al.: The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999, 60:427–435.
Katz SJ, Kessler RC, Lin E, Wells KB: Medication management of depression in the United States and Ontario. J Gen Intern Med 1998, 13:77–85.
Fifer SK, Mathias SD, Patrick DL, et al.: Untreated anxiety among adult primary care patients in a Health Maintenance Organization. Arch Gen Psychiatry 1994, 51:740–750.
Wittchen HU, Kessler RC, Beesdo K, et al.: Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002, 63(Suppl 8):24–34.
Kroenke K, Jackson JL, Chamberlin J: Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med 1997, 103:339–347.
Katon WJ, Walker EA: Medically unexplained symptoms in primary care. J Clin Psychiatry 1998, 59(Suppl 20):15–21.
Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ: Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993, 58:55–61.
Ball S, Goddard A, Shekhar A: Evaluating and treatment anxiety disorders in medical settings. J Postgrad Med 2002, 48:317. A brief overview on the prevalence of anxiety disorders, associated issues of comorbidity, and psychological and pharmacologic intervention options for patients presenting with comorbid anxiety disorders and medical illnesses in the PC setting.
Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, et al.: Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the anxiety and depression detector. Gen Hosp Psychiatry 2006, 28:108–118. A study validating the use of a five-item screening measure for PD, SocP, PTSD, GAD, and major depression in a sample of 801 PC patients.
Baldwin DS, Polkinghorn C: Evidence-based pharmacotherapy of generalized anxiety disorder. Int J Neuropsychopharmacol 2005, 8:298–302.
Roy-Byrne P, Stein M, Bystrisky A, Katon W: Pharmacotherapy of panic disorder: proposed guidelines for the family physician. J Am Board Fam Pract 1998, 11:282–290.
Zohar J, Westenberg HG: Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000, 403:39–49.
Culpepper L: Use of algorithms to treat anxiety in primary care. J Clin Psychiatry 2003, 64(Suppl 2):30–33.
Chambless DL, Sanderson WC, Shoham V, et al.: An update on empirically-validated therapies. Clin Psychol 1996, 49:5–18.
Tsao JC, Mystkowski J, Zucker B, Craske MG: Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: replication and extension. Behav Ther 2002, 33:493–509.
Craske MG, Golinelli D, Stein MB, et al.: Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting? Psychol Med 2005, 35:1645–1654.
Craske MG: Anxiety Disorder: Psychological Approaches to Theory and Treatment. Boulder, CO: Westview Press; 1999.
Proudfoot J, Goldberg D, Mann A, et al.: Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice. Psychol Med 2003, 33:217–227.
Craske MG, Barlow DH: The Mastery of Your Anxiety and Worry. New York: Oxford Press; 2005.
Nadiga DN, Hensley PL, Uhlenhuth EH: Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depress Anxiety 2003, 17:58–64.
Ballenger JC, Davidson JRT, Lecrubier Y, et al.: Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 1998, 59:54–60.
Otto MW, Pollack MH, Maki KM: Empirically-supported treatment for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol 2000, 68:556–563.
Noyes R, Garvey MJ, Cook B, Suelzer M: Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. Am J Psychiatry 1991, 148:517–523.
Hegel MT, Ravaris CL, Ahles TA: Combined cognitivebehavioral and time-limited alprazolam treatment of panic disorder. Behav Ther 1994, 25:183–195.
Otto MW, Pollack MH, Penava SJ, Zucker BG: Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther 1999, 37:763–770.
Barlow DH, Gorman JM, Shear MK, Woods SW: Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. J Am Med Assoc 2000, 283:2529–2536.
Blomhoff S, Haug TT, Hellstrom K, et al.: Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry 2001, 179:23–30.
Haug TT, Blomhoff S, Hellstrom K, et al.: Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial. Br J Psychiatry 2003, 182:312–318.
Otto MW, Smits JAJ, Reese HE: Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin Psychol Sci Prac 2005, 12:72–86.
Roy-Byrne PP, Craske MG, Stein MB, et al.: A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 2005, 62:290–298. A randomized controlled effectiveness study comparing a collaborative care model of treatment (CBT and pharmacotherapy) delivered by a midlevel behavioral health specialist with treatment as usual for anxiety disorders in a sample of 232 PC patients who met criteria for PD. Results demonstrated superiority of the collaborative care group over the treatment-as-usual group through the 12-month follow-up period.
Ballenger JC, Davidson JR, Lecrubier Y, et al.: Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 2001, 62(Suppl 11):53–58.
Shader RI, Greenblatt DJ: Some current treatment options for symptoms of anxiety. Psychiatry 1983, 44:21–30.
Wood SD, Kitchiner NJ, Bisson JI: Experience of implementing an adult educational approach to treating anxiety disorders. J Psychiatr Ment Health Nurs 2005, 12:95–99.
Price D, Beck A, Nimmer C, Bensen S: The treatment of anxiety disorders in a primary care HMO setting. Psychiatr Q 2000, 71:31–45.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demertzis, K.H., Craske, M.G. Anxiety in primary care. Curr Psychiatry Rep 8, 291–297 (2006). https://doi.org/10.1007/s11920-006-0065-4
Issue Date:
DOI: https://doi.org/10.1007/s11920-006-0065-4